Darwin Barney Getty

Darwin Barney could be an option for the Yankees

52 Comments

Many viewed Omar Infante as the most likely replacement for Robinson Cano, but that possibility is off the board now that he has reportedly agreed to a four-year, $30 million deal with the Royals. Bruce Levine of 670 The Score in Chicago now wonders whether the Yankees will revisit the idea of trading for Cubs second baseman Darwin Barney, as the two clubs have had previous discussions.

Barney is coming off a horrendous season in which he batted just .208/.266/.303 with seven home runs and 41 RBI over 555 plate appearances. While the 28-year-old is considered a strong defender at second base, he’s the owner of a .628 career OPS. That’s only slightly better than Brendan Ryan (.619 career OPS). Not exactly ideal.

Barney wouldn’t cost much in a trade, but the Yankees will likely find more appealing alternatives in the free agent and trade markets. Assuming they want to keep Kelly Johnson in a utility role, they could sign Mark Ellis to play second base and bring back either Mark Reynolds or Eric Chavez as another option to play third.

Report: Arquimedes Caminero likely to sign with Yomiuri Giants

SEATTLE, WA - AUGUST 21: Arquimedes Caminero #48 of the Seattle Mariners delivers a pitch during a game against the Milwaukee Brewers at Safeco Field on August 21, 2016 in Seattle, Washington. The Brewers won the game 7-6. (Photo by Stephen Brashear/Getty Images)
Getty Images
Leave a comment

Mariners’ right-hander Arquimedes Caminero is nearing a deal with the Yomiuri Giants of Nippon Professional Baseball, according to Bob Dutton of the Tacoma News Tribune. The club has reportedly agreed to sell the 29-year-old’s contract, Dutton writes, though no official move has been announced by either team yet. Caminero is under club control through 2020 and currently ineligible for arbitration.

The right-hander began the 2016 season with the Pirates but was sent to the Mariners in a trade for Seattle minor leaguers Jake Brentz and Pedro Vasquez in order to clear space in the Bucs’ bullpen. With the Mariners, Caminero produced a 3.66 ERA and 8.2 K/9 through 19 2/3 innings in the second half of the year. Although he boasts an electric fastball, one which consistently averaged 98.7 m.p.h. in 2016, his success rate has been tempered by poor control throughout his major league career. According to Dutton, the Mariners’ willingness to sell Caminero’s contract was a strong indication that they did not see him as a viable contender for their 2017 bullpen or as a potential trade chip further down the line.

Should the deal go through, the right-hander will be the second former Mariner to sign with a Japanese club for the 2017 season. Per Dutton’s report, outfielder Stefen Romero also picked up a contract with the Orix Buffaloes of NPB in late November.

Gerrit Cole set to begin throwing program

PITTSBURGH, PA - AUGUST 24:  Gerrit Cole #45 of the Pittsburgh Pirates sits in the dugout in the second inning during the game against the Houston Astros at PNC Park on August 24, 2016 in Pittsburgh, Pennsylvania. (Photo by Justin Berl/Getty Images)
Getty Images
Leave a comment

During the Pirates’ FanFest on Saturday, right-hander Gerrit Cole announced that he is back up to full health after being shut down with elbow inflammation in September. Per Rob Biertempfel of the Pittsburgh Tribune-Review, Cole said he’ll start a throwing program on Monday as he works on regaining his form for the 2017 season.

The 26-year-old pitched through 116 innings for the Pirates in 2016, delivering a 3.88 ERA and 2.5 WARP before landing on the disabled list in June with a triceps strain and again in August with elbow inflammation. It was a steep drop for the right-hander, who saw a considerable spike in his ERA and BB/9 rate and struggled to strike out batters at the 8.7 mark he managed in 2015.

The upside? Inflammation was the worst of Cole’s issues in 2016, and while the newfound health issues didn’t help his case for an extension, a more serious injury doesn’t appear to be on the horizon.